Search

Search Constraints

You searched for: Author/Creator Raggi, Daniele

Search Results

21. MP50-03 SYSTEMATIC DEFINITION OF TREATMENT MODALITY AND CLINICAL OUTCOMES REPORTING SYSTEM IN CASE OF SURGICAL TREATMENT FOR VON HIPPEL-LINDAU RENAL CELL CARCINOMA. (May 2022)

22. MP50-09 IMAGING INTENSITY AFTER SURGERY FOR CLEAR CELL RENAL CELL CARCINOMA. (May 2022)

23. MP51-14 IMPACT OF 68GA-PSMA PET/CT AND METASTASIS-DIRECTED THERAPY ON CLINICAL RECURRENCE IN PATIENTS WITH BIOCHEMICAL RECURRENCE AFTER RADICAL PROSTATECTOMY. RESULTS FROM A SINGLE CENTER SERIES. (May 2022)

24. MP56-02 NEOADJUVANT PEMBROLIZUMAB MAY RESULT IN LONG-TERM OUTCOME IMPROVEMENT IN BIOMARKER-UNSELECTED PATIENTS WITH MUSCLE-INVASIVE BLADDER CANCER (MIBC): UPDATED RESULTS FROM PURE-01. (May 2022)

25. MP56-04 THE ROLE OF FDG PET IN THE STAGING OF BLADDER CANCER PATIENTS CANDIDATE FOR RADICAL CYSTECTOMY. (May 2022)

27. Not All Adverse Pathology Features Are Equal: Identifying Optimal Candidates for Adjuvant Radiotherapy Among Patients With Adverse Pathology at Radical Prostatectomy. Issue 5 (5th November 2022)

28. Optimising the selection of candidates for neoadjuvant chemotherapy amongst patients with node‐positive penile squamous cell carcinoma. (1st April 2020)

29. Outcome of patients with advanced upper tract urothelial carcinoma treated with immune checkpoint inhibitors: A systematic review and meta-analysis. (March 2021)